Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-10-18 Purchase |
2023-10-31 07:08 am |
Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund II L.P. Israel Biotech Fund GP Partners L.P. Israel Biotech Fund GP Partners II L.P. I.B.F. Management Ltd. 10% Owner |
1,317,716 | $0 | $0 | 1,094,091 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-01 Exercise |
2024-03-06 07:13 am |
2023-11-17 N/A |
Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund II L.P. Israel Biotech Fund GP Partners L.P. Israel Biotech Fund GP Partners II L.P. I.B.F. Management Ltd. Director 10% Owner |
15,000,000 | $0 | 51,900,000 (Indirect) |
View |
| 2024-02-07 Exercise |
2024-02-12 2:16 pm |
N/A N/A |
Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund II L.P. Israel Biotech Fund GP Partners L.P. Israel Biotech Fund GP Partners II L.P. I.B.F. Management Ltd. Director 10% Owner |
27,847,159 | $0.4 | 105,571,313 (Indirect) |
View |
| 2024-02-07 Tax Withholding |
2024-02-12 2:16 pm |
N/A N/A |
Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund II L.P. Israel Biotech Fund GP Partners L.P. Israel Biotech Fund GP Partners II L.P. I.B.F. Management Ltd. Director 10% Owner |
5,294,486 | $1.2465 | 105,571,313 (Indirect) |
View |
| 2024-02-07 Exercise |
2024-02-12 2:16 pm |
2023-11-17 2028-11-17 |
Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund II L.P. Israel Biotech Fund GP Partners L.P. Israel Biotech Fund GP Partners II L.P. I.B.F. Management Ltd. Director 10% Owner |
27,847,159 | $0 | 105,571,313 (Indirect) |
View |
Ownership |
2023-11-08 4:01 pm |
N/A N/A |
Ayala Pharmaceuticals Inc. | ADXS | Cabilly Yuval Director |
0 | $0 | 1,298,639 (Indirect) |
View |
| 2023-10-18 Other |
2023-10-23 06:43 am |
N/A N/A |
Ayala Pharmaceuticals Inc. | ADXS | aMoon Growth Fund Limited Partnership 10% Owner |
0 | $0 | 560,602 (Direct) |
View |
Ownership(A) |
2023-09-29 06:10 am |
N/A N/A |
Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund GP Partners L.P. I.B.F. Management Ltd. 10% Owner |
0 | $0 | 621,253 (Indirect) |
View |
Ownership |
2023-09-11 12:41 pm |
N/A N/A |
Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. 10% Owner |
0 | $0 | 621,253 (Indirect) |
View |
Ownership |
2023-01-30 06:37 am |
N/A N/A |
Ayala Pharmaceuticals Inc. | ADXS | aMoon Growth Fund Limited Partnership Schindel Yair Chaim 10% Owner |
0 | $0 | 560,602 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-23 6:19 pm |
N/A 2031-06-09 |
Ayala Pharmaceuticals Inc. | ADXS | SIDRANSKY DAVID Director |
4,730 | $0 | 5,245 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-23 6:18 pm |
N/A 2028-03-20 |
Ayala Pharmaceuticals Inc. | ADXS | GOLDBERG MURRAY A Director |
7,963 | $0 | 7,963 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-23 6:17 pm |
N/A 2030-08-17 |
Ayala Pharmaceuticals Inc. | ADXS | Bisker-Leib Vered Director |
3,981 | $0 | 3,981 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-23 6:16 pm |
N/A 2028-03-20 |
Ayala Pharmaceuticals Inc. | ADXS | Spiegel Robert J. Director |
7,963 | $0 | 7,963 (Direct) |
View |
Ownership |
2021-02-16 4:30 pm |
N/A 2030-11-16 |
Advaxis Inc. | ADXS | Gitelman Igor Chief Accounting Officer |
0 | $0 | 50,000 (Direct) |
View |
| 2020-05-04 Option Award |
2020-05-05 4:00 pm |
N/A 2030-05-04 |
Advaxis Inc. | ADXS | Henderson Molly Executive Vice President & CFO |
50,000 | $0 | 50,000 (Direct) |
View |
| 2020-05-04 Option Award |
2020-05-05 4:00 pm |
N/A 2030-05-04 |
Advaxis Inc. | ADXS | Khleif Samir N Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2020-05-04 Option Award |
2020-05-05 4:00 pm |
N/A 2030-05-04 |
Advaxis Inc. | ADXS | APPEL RONI Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2020-05-04 Option Award |
2020-05-05 4:00 pm |
N/A 2030-05-04 |
Advaxis Inc. | ADXS | Berlin Kenneth A President and CEO |
50,000 | $0 | 50,000 (Direct) |
View |
| 2020-05-04 Option Award |
2020-05-05 4:00 pm |
N/A 2030-05-04 |
Advaxis Inc. | ADXS | PATTON JAMES P Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2020-05-04 Option Award |
2020-05-05 4:00 pm |
N/A 2030-05-04 |
Advaxis Inc. | ADXS | SIDRANSKY DAVID Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2020-05-04 Option Award |
2020-05-05 4:00 pm |
N/A 2030-05-04 |
Advaxis Inc. | ADXS | BERMAN RICHARD J Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2020-05-04 Option Award |
2020-05-05 4:00 pm |
N/A 2030-05-04 |
Advaxis Inc. | ADXS | Gutierrez Andres Executive Vice President & CMO |
50,000 | $0 | 50,000 (Direct) |
View |